Combinational Therapy for Pancreatic Cancer

Min Li - The University of Oklahoma Health Sciences Center

Oct 20, 2016
Main Auditorium
Host: M. Schwab

Dr. Li’s laboratory is currently investigating molecular and cellular mechanisms of cancer pathogenesis and developing new therapies for human cancers, including pancreatic cancer and brain tumor. The research in Li’s laboratory has both basic and translational components and expands in multiple directions, which include zinc transport, nutrition uptake and metabolism, protein-protein interaction, microRNA, drug resistance, cancer prevention and therapy (shRNA therapy, small molecule therapy, and nutrition/diet prevention and therapy). Li’s laboratory is funded by both the NIH/NCI (R01CA138701, R21CA133604) as well as private foundations. 

to top
powered by webEdition CMS